To gain further insight into FNIPs expression and sensitivity of tumours to Hsp90 inhibitors, we examined tumours and adjacent normal tissues from patients with renal cell carcinoma (RCC), the most common type of kidney cancer23. The gene discussed is HSP90AA1; the disease is hereditary clear cell renal cell carcinoma.